Jean Boulle Group Receives US$47 million Cash Investment from Major Strategic Investor in Proprietary VDYNE Technology
LUXEMBOURG, October 24, 2022 /EINPresswire.com/ -- The Jean Boulle Group (“the Group”) is pleased to announce a US$47 million cash investment (“the Investment”) in Jean Boulle Medtech’s proprietary VDYNE heart valve technology from a new major strategic …